Search Results - "sodium/glucose cotransporter 2"

Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists by Apurva Khedagi, Cara Hoke, Michelle Kelsey, Andrea Coviello, W. Schuyler Jones, Larry R. Jackson, II, Manesh R Patel, Rob W. McGarrah, Neha J Pagidipati, Nishant P. Shah

Connect to this object online.

Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery by Jinjoo Lee, Seungjin Noh, Suhyun Lim, Bonglee Kim

Connect to this object online.

Empagliflozin in the treatment of type 2 diabetes: evidence to date by Shubrook JH, Baradar Bokaie B, Adkins SE

Connect to this object online.

Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans by Min-Soo Kim, Yoo-Kyung Song, Ji-Soo Choi, Hye Young Ji, Eunsuk Yang, Joon Seok Park, Hyung Sik Kim, Min-Joo Kim, In-Kyung Cho, Suk-Jae Chung, Yoon-Jee Chae, Kyeong-Ryoon Lee

Connect to this object online.

Empagliflozin improves chronic hypercortisolism-induced abnormal myocardial structure and cardiac function in mice by Qing-Qing Zhang, Guo-Qing Li, Yi Zhong, Jie Wang, An-Ning Wang, Xiao Zhou, Xiao-Ming Mao

Connect to this object online.

Diabetic kidney disease treatment: new perspectives by Li-Li Tong, Sharon G. Adler

Connect to this object online.

Management of Heart Failure in Patients With Diabetes Mellitus in the UAE: A Call to Action by Hani Sabbour MD, Aftab Ahmad MD

Connect to this object online.

The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/− Mice by Weiling Leng, Xinshou Ouyang, Xiaotian Lei, Mingxia Wu, Liu Chen, Qinan Wu, Wuquan Deng, Ziwen Liang

Connect to this object online.

Kidney Function Assessment in African American Patients: A Narrative Review for Pharmacists by Dhakrit Rungkitwattanakul, Weerachai Chaijamorn, Eunice Han, Mohammed Aldhaeefi

Connect to this object online.

A Review of Contemporary and Future Pharmacotherapy for Chronic Heart Failure in Children by Bibhuti B. Das

Connect to this object online.

SGLT-2 inhibitors in heart failure: a literature review on mechanisms, efficacy and safety by Klaudia Kułak, Katarzyna Chamera-Cyrek, Izabela Janik, Martyna Kuśmierska, Anna Koman, Marzena Pliszka, Katarzyna Gadżała, Karolina Palacz, Izabela Sztybór, Sabina Przygodzka

Connect to this object online.

Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin by Shreya Pujara MD, Adriana Ioachimescu MD, PhD

Connect to this object online.

Obesity and chronic kidney disease: A current review by Saira Nawaz, Rajkumar Chinnadurai, Saif Al‐Chalabi, Philip Evans, Philip A. Kalra, Akheel A. Syed, Smeeta Sinha

Connect to this object online.

Clinical studies of dapagliflozin in pediatric patients: a rapid review by Paige M. Grube, Robert D. Beckett

Connect to this object online.

SGLT2 Inhibitor-Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism by Batoul Dia, Sahar Alkhansa, Rachel Njeim, Sarah Al Moussawi, Theresa Farhat, Antony Haddad, Mansour E. Riachi, Rashad Nawfal, William S. Azar, Assaad A. Eid

Connect to this object online.

Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy by Kamilya A. Schumacher BA, Aidar R. Gosmanov MD, PhD, FACE

Connect to this object online.

Chinese botanical drugs targeting mitophagy to alleviate diabetic kidney disease, a comprehensive review by Leilei Ma, Jing Li, Xiaotian Zhang, Wei Zhang, Chen Jiang, Bo Yang, Hongtao Yang

Connect to this object online.

Management of Patients with Chronic Heart Failure and Diabetes Mellitus by E. V. Reznik, T. L. Nguyen, G. N. Golukhov

Connect to this object online.

New Hypoglycemic Drugs: Combination Drugs and Targets Discovery by Xiayun Ni, Lei Zhang, Xiaojun Feng, Liqin Tang

Connect to this object online.

The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile by Alana Aragón-Herrera, Alana Aragón-Herrera, Manuel Otero-Santiago, Laura Anido-Varela, Sandra Moraña-Fernández, Manuel Campos-Toimil, Tomás García-Caballero, Luis Barral, Estefanía Tarazón, Estefanía Tarazón, Esther Roselló-Lletí, Esther Roselló-Lletí, Manuel Portolés, Manuel Portolés, Oreste Gualillo, Isabel Moscoso, Ricardo Lage, José Ramón González-Juanatey, José Ramón González-Juanatey, Sandra Feijóo-Bandín, Sandra Feijóo-Bandín, Francisca Lago, Francisca Lago

Connect to this object online.